Shanghai Hengrui Pharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd., explained in plain language.
-
New drug shows promise for dialysis Patients' hormone imbalance
Disease control CompletedThis study tested whether a new drug called SHR6508 could safely and effectively treat a serious hormone imbalance (secondary hyperparathyroidism) in people with kidney failure who are on regular dialysis. It involved 498 participants in China and compared the drug's effects to a…
Phase: PHASE3 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Long-Term skin treatment study seeks to confirm safety for eczema patients
Disease control CompletedThis study followed 79 adults with moderate to severe atopic dermatitis (eczema) who had already participated in earlier research on the drug SHR-1819. The main goal was to gather more information on the long-term safety and effectiveness of the injection. Participants continued …
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC